PURE Bioscience Q3 net product sales $440K, net loss $857K; loss per share ($0.01)

PURE BIOSCIENCE, INC.

2024-Q3 EPS reported -$0.03 revenue$1,483,000

Net product sales $440,000 for Q3 FY2024, up 8% vs $406,000 in prior-year quarter.
Net loss $857,000; narrower than $876,000 in Q3 FY2023; net loss per share unchanged ($0.01).
For the nine months ended April 30, 2024, net product sales $1,483,000, net loss $2,594,000.
Company transitioning to distributor model; new Tier Pricing Agreement developed for distributor margins.
Social media platform engagement up 167% in past 90 days; followers up nearly 70%.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.